Interpretation of Your Liver Enzyme Panel
Your alkaline phosphatase of 139 U/L is mildly elevated, while your AST of 16 U/L and ALT of 19 U/L are within normal limits—in fact, they are in the optimal healthy range. This pattern suggests a cholestatic process (bile flow issue) rather than hepatocellular injury, and warrants further evaluation to identify the underlying cause.
Understanding Your Results
Alkaline Phosphatase (ALP) 139 U/L
- Your ALP is mildly elevated above the typical upper limit of normal (which ranges from 40–150 U/L depending on the laboratory), though it remains below 1.5× the upper limit. 1
- ALP elevation without transaminase elevation indicates a cholestatic pattern rather than liver cell damage, and can originate from the liver (bile ducts), bone, intestine, or placenta. 1
- Common causes of isolated ALP elevation include:
- Biliary obstruction or cholestasis (gallstones, bile duct strictures)
- Bone disorders (Paget's disease, bone metastases, healing fractures, vitamin D deficiency)
- Medications (especially those causing cholestasis)
- Infiltrative liver diseases (sarcoidosis, amyloidosis)
- Malignancy (primary liver tumors, metastatic disease) 2
AST 16 U/L and ALT 19 U/L
- Both your AST and ALT are well within the normal range and actually represent optimal values. 3
- Updated reference ranges suggest that truly healthy ALT levels are:
- Your ALT of 19 U/L is in the lowest quartile of healthy individuals, indicating no hepatocellular injury. 3, 4
- Your AST of 16 U/L is similarly optimal, well below the sex-specific upper limits of 32 U/L for men and 26 U/L for women. 7
What This Pattern Means
The ALP/Transaminase Discordance
- An elevated ALP with normal AST and ALT strongly suggests a cholestatic or infiltrative process rather than hepatocellular injury. 1
- This pattern requires investigation of the biliary system and consideration of non-hepatic sources of ALP (bone, intestine). 1, 3
Calculating the R-Value
- The R-value helps classify liver injury patterns:
- R = (ALT ÷ ULN for ALT) / (ALP ÷ ULN for ALP)
- R ≥ 5 = hepatocellular injury
- R ≤ 2 = cholestatic injury
- 2 < R < 5 = mixed injury 3
- In your case, with normal transaminases and mildly elevated ALP, the R-value would be <2, confirming a cholestatic pattern. 3
Recommended Evaluation
Initial Laboratory Testing
Order the following tests to complete your liver panel and identify the source of ALP elevation: 1, 3
- Gamma-glutamyl transferase (GGT): If elevated, confirms hepatobiliary origin of ALP elevation; if normal, suggests bone or other non-hepatic source 1, 3
- Total and direct bilirubin: To assess for cholestasis or biliary obstruction 1, 3
- Albumin and prothrombin time/INR: To assess liver synthetic function 1, 3
- Complete blood count with platelets: To screen for underlying hematologic abnormalities 1
First-Line Imaging
- Abdominal ultrasound is the recommended initial imaging study with 84.8% sensitivity and 93.6% specificity for detecting biliary obstruction, hepatic steatosis, and structural liver abnormalities. 3
- Ultrasound can identify:
- Biliary dilation or obstruction (gallstones, strictures)
- Focal liver lesions
- Hepatic steatosis
- Portal hypertension features 3
Additional Testing Based on GGT Result
If GGT is elevated (hepatobiliary source confirmed): 1, 3
- Consider viral hepatitis serologies (HBsAg, anti-HCV) if not already done
- Review all medications for hepatotoxic potential using the LiverTox® database
- Consider autoimmune markers (ANA, anti-mitochondrial antibody) if other causes excluded
If GGT is normal (non-hepatic source likely): 1, 3
- Check vitamin D level (deficiency causes bone ALP elevation)
- Consider bone-specific ALP or ALP isoenzymes to confirm bone origin
- Evaluate for bone disorders (X-rays if clinically indicated)
Important Clinical Context
Why Normal Transaminases Matter
- Normal ALT and AST effectively rule out significant hepatocellular injury at this time, though they do not exclude all forms of liver disease. 8
- Up to 50% of patients with chronic hepatitis C can have normal transaminases, so normal enzymes do not exclude chronic liver disease in high-risk individuals. 8
- However, your pattern (isolated ALP elevation) is not consistent with viral hepatitis, which typically elevates transaminases first. 1, 8
Cardiovascular Considerations
- Even mildly elevated ALP within the "normal" range has been associated with increased cardiovascular risk in large prospective studies, with a dose-dependent relationship. 9
- This association persists even when ALP is 40–150 U/L, suggesting that regular monitoring may help identify individuals at higher cardiovascular risk. 9
Common Pitfalls to Avoid
- Do not assume isolated ALP elevation is benign without proper evaluation—it may represent early biliary obstruction, infiltrative disease, or malignancy. 1, 3
- Do not overlook bone sources of ALP elevation, especially in the setting of vitamin D deficiency, recent fractures, or bone metastases. 2
- Do not order extensive hepatology workup before confirming the source of ALP with GGT—this simple test directs all subsequent evaluation. 1, 3
- Do not ignore medications as a cause—many drugs cause cholestatic liver injury with isolated ALP elevation. 3
Next Steps
Your immediate action plan should be: 1, 3
- Order GGT, bilirubin (total and direct), albumin, PT/INR, and CBC to complete your liver panel
- Schedule abdominal ultrasound to evaluate the biliary system and liver structure
- Review all current medications and supplements for potential hepatotoxic effects
- Repeat ALP in 2–4 weeks to establish whether this is a persistent or transient elevation
- If ALP remains elevated or increases, or if ultrasound shows abnormalities, refer to gastroenterology/hepatology for further evaluation
If GGT is normal and ultrasound is unremarkable, consider bone evaluation with vitamin D level and bone-specific ALP. 1, 3